Abbott Vascular Medical Device Registry (NCT04573660)
🩺 Plain-English Summary (8th-Grade Level)
The AV-MDR is a prospective, non-randomized, open-label, multi-center registry. The purpose of the AV-MDR study is to proactively collect and evaluate clinical data on the usage of the devices in scope within their intended use with the aim of confirming safety and performance throughout their expected lifetime, ensuring the continued acceptability of identified risks, detecting emerging risks on the basis of factual evidence, ensuring the continued acceptability of the benefit-risk ratio, and identifying possible systematic misuse or off-label usage such that the intended use can be verified as appropriate.
Who can join: Review the eligibility criteria below.
Location: University Hospital - Univ. of Alabama at Birmingham (UAB) — Birmingham, Alabama
Age range: 18 Years
🧪 Interventions in This Study
- Coronary and peripheral stents (DEVICE)
- Pacing catheters (DEVICE)
- Vascular plugs (DEVICE)
- Measurement and imaging (FFR and OCT) (DEVICE)
- Peripheral dilatation catheters (DEVICE)
- Coronary dilatation catheters (DEVICE)
- Coronary and peripheral guidewires (DEVICE)
- Vessel closure/compression devices (DEVICE)
- Vascular access introducers (DEVICE)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (37 Sites)
Showing the first 25 of 37 sites.
- University Hospital - Univ. of Alabama at Birmingham (UAB) — Birmingham, Alabama
- Arkansas Heart Hospital — Little Rock, Arkansas
- Kaiser Permanente Los Angeles Medical Center — Los Angeles, California
- Northwestern Memorial Hospital — Chicago, Illinois
- Bryan Heart — Lincoln, Nebraska
- Ohio State University — Columbus, Ohio
- Wellmont CVA Heart Institute — Kingsport, Tennessee
- Perth Institute of Vascular Research — Nedlands, WAUS
- Sir Charles Gairdner Hospital — Nedlands, WAUS
- Universitätsklinik Graz — Graz, Styria
- Onze-Lieve-Vrouwziekenhuis Campus Aalst — Aalst, Eflndrs
- AZ Sint-Blasius Ziekenhuis — Dendermonde, Eflndrs
- The First Affiliated Hospital of Xi'an Jiaotong University — Xi'an, Shaanxi
- Jinhua Municipal Central Hospital — Jinhua, Zhejian
- Ningbo First Hospital — Ningbo, Zhejian
- CH Chartres — Chartres, Centre-Val de Loire
- Hôpital Paris Saint-Joseph — Paris, Ile
- Cardioangiologisches Centrum am Bethanien Krankenhaus — Frankfurt am Main, Hesse
- UNIVERSITATSMEDIZIN der Johannes Gutenberg-Universität Mainz — Mainz, Rhinela
- Universitätsklinikum Leipzig AÖR — Leipzig, Saxony
- Herz- u. Gefäßzentrum Bad Bevensen — Bad Bevensen, Saxon
- Universitätsklinikum Schleswig-Holstein Campus Kiel — Kiel, Schlesw
- Semmelweis University — Budapest, Budapest
- Ospedale San Raffaele — Milan, Lombard
- Centro Cardiologico Monzino — Milan, Lombard
📞 Contact the Study Coordinator
Phone: (714) 926-8292
Email: sharanjeet.dhanjal@abbott.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Acute Myocardial Infarction
- COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial — Minneapolis, Minnesota
- Molecular and Morphologic Characterization of Circulating Endothelial Cells — La Jolla, California
- Arrhythmia Detection After MI — Pittsburgh, Pennsylvania
- Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease — Los Angeles, California
Explore by condition: All Acute Myocardial Infarction clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.